Holotropic Breathwork vs Psilocybin-Assisted Therapy

A side-by-side comparison of recorded mechanisms, evidence review status, related condition topics, and philosophical roots.

At a glance

Source checks, condition-specific assessments and expert review are separate steps. Each assessment applies only to its stated population and use. Topic links do not establish comparative effectiveness.

Holotropic Breathwork

Tradition
Psychedelic
Founder
Stanislav Grof / Christina Grof (1976)
Review status
Assessment not yet completed
Focus
Experiential + Integration
Format
Group (workshop format); individual adaptations exist
Duration
Full-day workshops or multi-day intensives; individual sessions less common

Psilocybin-Assisted Therapy

Tradition
Psychedelic
Founder
Griffiths / Carhart-Harris (2016)
Review status
1 condition assessment available
Official sources
Guidelines and official sources (3)

2 clinical guideline checks · 1 regulatory source check

Read the recommendation and its scope. A source may discuss an approach without recommending it.

  • FDA accelerates action on treatments for serious mental illness following Executive Order

    US Food and Drug Administration · 2026-04-24 · Regulatory source · National priority voucher announcement

    Not a treatment recommendation

    FDA announced priority vouchers for psilocybin studies in April 2026. This establishes development activity, not approval or psychotherapy endorsement.

    Scope: Companies studying psilocybin for TRD and MDD

    Source checked

  • Management of Major Depressive Disorder

    VA/DoD · Version 4.0, February 2022; evidence through January 2021 · Clinical guideline · Recommendation 35

    Recommendation against the stated use

    VA/DoD strongly recommends against psilocybin for MDD outside research. This 2022 guideline used evidence through January 2021 and does not review subsequent trials.

    Scope: Psilocybin for MDD outside research settings

    Source checked

  • Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder

    VA/DoD · 2023 · Clinical guideline · Recommendation 17; Table 6, p.37

    Discussed in the source

    VA/DoD finds insufficient evidence for or against psilocybin for PTSD. The statement does not separately establish a psychotherapy-protocol recommendation.

    Scope: Psilocybin pharmacotherapy for adult PTSD; evidence reviewed through May 2022.

    Source checked

Focus
Experiential + Processing
Format
Individual
Duration
Short (1-3 doses)

Condition-specific assessments

Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.

Existential & Meaning-Making Concerns

Population and scope: Carefully selected adults with a potentially life-threatening cancer diagnosis and anxiety/mood symptoms, receiving psilocybin with substantial preparation, monitored sessions and follow-up support.

Randomized studies

Griffiths et al. (2016) randomized dose order in a crossover study: 56 people were assigned and 51 completed at least one session. Higher-dose treatment favored several mood and existential outcomes compared with the very-low-dose condition, including life meaning and death acceptance. After crossover at five weeks, the six-month observations lacked an unexposed comparison. The small, predominantly White, highly educated sample, expectancy and masking limits, and intensive support restrict generalization. Transient anxiety, psychological distress and blood-pressure increases occurred. This is a trial-design assessment for that supervised research context, not a guideline endorsement or evidence for all meaning-making concerns or unsupervised use.

Source assessment dated

How they work

Holotropic Breathwork

Core mechanism: Altered breathing pattern induces non-ordinary state that bypasses ordinary ego defenses, allowing access to perinatal, biographical, and transpersonal material that can be processed and integrated through somatic release, imagery, and mandala drawing

Ontology: The psyche as multi-layered: biographical, perinatal (birth trauma), and transpersonal, with healing available at all levels through non-ordinary states that transcend ordinary rational consciousness

Psilocybin-Assisted Therapy

Core mechanism: Psilocybin disrupts default mode network activity; on the standard account the mystical-type experience this can occasion is what produces lasting shifts in perspective and meaning, though whether that experience is necessary to the effect is actively disputed

Ontology: Rigid self-referential processing (depression) or compulsive patterns maintained by entrenched neural networks

Related condition topics

These editorial cross-references organize reading. A shared link does not mean both approaches are effective, recommended, or interchangeable for that condition.

3 shared · 3 Holotropic Breathwork-only · 0 Psilocybin-Assisted Therapy-only

Linked only in the Holotropic Breathwork entry

What each assumes — and misses

Holotropic Breathwork

Philosophical roots: Grof's cartography of the psyche (COEX systems, BPM matrices); James (varieties of religious experience); Jung (collective unconscious, archetypes); Maslow (peak experiences, transpersonal psychology); Perennial philosophy

Blind spots: No controlled research base; contraindications are significant and screening is essential; transpersonal framework not accepted by mainstream clinical psychology; risk of retraumatization without adequate support; facilitator quality varies widely outside certified programs; not suitable for many clinical populations

Therapeutic voice: Breathe faster and deeper than you normally would, and then stop steering. Whatever comes up is what needed to come up. Your sitter stays with you the whole time.

Psilocybin-Assisted Therapy

Philosophical roots: James (mystical experience); Huxley (doors of perception, reducing valve theory); Watts (ego dissolution); Buddhist concepts (non-self, interconnection); Carhart-Harris (entropic brain hypothesis)

Blind spots: Not FDA approved; challenging experiences can be destabilizing; standardization of therapy component still developing

Therapeutic voice: Whatever comes, let it come. Whatever goes, let it go. Trust the process.

Choosing between them

Holotropic Breathwork and Psilocybin-Assisted Therapy both sit within the Psychedelic tradition — they share a worldview about what suffering is and how change happens. Differences are more often about technique and emphasis than about underlying theory.

For deeper coverage: see the full Holotropic Breathwork and Psilocybin-Assisted Therapy pages, or use the interactive comparison tool to add more modalities to this comparison.